NASDAQ:CNTB

Connect Biopharma Holdings Limited American Depositary Shares Stock Forecast, Price & News

$16.95
-0.10 (-0.59 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.32
Now: $16.95
$17.75
50-Day Range N/A
52-Week Range
$15.29
Now: $16.95
$23.29
Volume150,668 shs
Average Volume228,361 shs
Market Capitalization$946.10 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for the treatment of inflammatory allergic diseases, such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes into the periphery that is in Phase II for the treatment of autoimmune-related inflammation diseases; CBP-174, a small molecule histamine receptor 3 antagonist for oral administration, which is in a preclinical stage to treat chronic itch associated with skin inflammation; and CBP-233, a preclinical stage humanized antibody against interleukin-33, a cytokine involved in T helper 2 inflammation. The company was founded in 2012 and is headquartered in Taicang, China.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CNTB
CUSIPN/A
CIKN/A
Phone86 512 5357 7866
Employees62
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$946.10 million
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Connect Biopharma Holdings Limited (CNTB)
March 29, 2021 |  au.finance.yahoo.com
News for Connect Biopharma Holdings Limited (spons. ADRs)
March 23, 2021 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

1.00 out of 5 stars

Medical Sector

1073rd out of 2,019 stocks

Biotechnology Industry

47th out of 145 stocks

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$16.95
-0.10 (-0.59 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CNTB News and Ratings via Email

Sign-up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Connect Biopharma Holdings Limited American Depositary Shares (NASDAQ:CNTB) Frequently Asked Questions

What stocks does MarketBeat like better than Connect Biopharma Holdings Limited American Depositary Shares?

Wall Street analysts have given Connect Biopharma Holdings Limited American Depositary Shares a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Connect Biopharma Holdings Limited American Depositary Shares wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Connect Biopharma Holdings Limited American Depositary Shares' key executives?

Connect Biopharma Holdings Limited American Depositary Shares' management team includes the following people:
  • Dr. William Pan, Pres & Chairman of Directors (Age 56)
  • Dr. Wei Zheng, CEO & Director (Age 57)
  • Mr. Eric J. Hall C.F.A., CFA, Interim Chief Financial Officer (Age 66)
  • Dr. Selwyn Ho MBBS, MB BS, Chief Bus. Officer (Age 50)
  • Dr. Lei Sun Ph.D., VP of Biologics & Head of CMC (Age 57)

Who are some of Connect Biopharma Holdings Limited American Depositary Shares' key competitors?

When did Connect Biopharma Holdings Limited American Depositary Shares IPO?

(CNTB) raised $150 million in an initial public offering on Friday, March 19th 2021. The company issued 9,400,000 shares at a price of $15.00-$17.00 per share. Jefferies, VB Leerink, Piper Sandler and CICC served as the underwriters for the IPO.

What is Connect Biopharma Holdings Limited American Depositary Shares' stock symbol?

Connect Biopharma Holdings Limited American Depositary Shares trades on the NASDAQ under the ticker symbol "CNTB."

When does the company's quiet period expire?

Connect Biopharma Holdings Limited American Depositary Shares' quiet period expires on Wednesday, April 28th. Connect Biopharma Holdings Limited American Depositary Shares had issued 11,250,000 shares in its public offering on March 19th. The total size of the offering was $191,250,000 based on an initial share price of $17.00. During the company's quiet period, underwriters and any insiders involved in the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of Connect Biopharma Holdings Limited American Depositary Shares?

Shares of CNTB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Connect Biopharma Holdings Limited American Depositary Shares' stock price today?

One share of CNTB stock can currently be purchased for approximately $16.95.

How much money does Connect Biopharma Holdings Limited American Depositary Shares make?

Connect Biopharma Holdings Limited American Depositary Shares has a market capitalization of $946.10 million.

How many employees does Connect Biopharma Holdings Limited American Depositary Shares have?

Connect Biopharma Holdings Limited American Depositary Shares employs 62 workers across the globe.

What is Connect Biopharma Holdings Limited American Depositary Shares' official website?

The official website for Connect Biopharma Holdings Limited American Depositary Shares is www.connectbiopharm.com.

How can I contact Connect Biopharma Holdings Limited American Depositary Shares?

The company can be reached via phone at 86 512 5357 7866.


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.